Background Artemisinin-based combination therapies are the recommended first-line treatments
of falciparum malaria in all countries with endemic disease. There are recent concerns …

Malaria, the most prevalent and most pernicious parasitic disease of humans, is estimated
to kill between one and two million people, mainly children, each year. Resistance has …

Background Tuberculous meningitis kills or disables more than half of those affected with the
disease. Previous studies have been too small to determine whether adjunctive treatment …

Background Severe forms of dengue, the most important arboviral infection of man, are
associated with haemorrhagic disease and a generalised vascular leak syndrome. The …

Burkholderia pseudomallei is a potential bioterror agent and the causative agent of melioidosis,
a severe disease that is endemic in areas of Southeast Asia and Northern Australia. …

Background Artemisinin resistance in Plasmodium falciparum has emerged in Southeast Asia
and now poses a threat to the control and elimination of malaria. Mapping the geographic …

Background The borders of Thailand harbour the world's most multidrug resistant Plasmodium
falciparum parasites. In 1984 mefloquine was introduced as treatment for uncomplicated …

Background Severe malaria is a major cause of childhood death and often the main reason
for paediatric hospital admission in sub-Saharan Africa. Quinine is still the established …

Background Artemisinin-resistant falciparum malaria has arisen in western Cambodia. A
concerted international effort is underway to contain artemisinin-resistant Plasmodium …

Plasmodium vivax threatens almost 40% of the world’s population, resulting in 132-391 million
clinical infections each year. Most of these cases originate from South East Asia and the …